| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.61B | 5.66B | 4.75B | 6.16B | 5.58B | 2.96B |
| Gross Profit | 2.75B | 3.12B | 2.80B | 4.02B | 3.60B | 1.28B |
| EBITDA | 2.30B | 3.00B | 2.68B | 3.82B | 3.56B | 1.36B |
| Net Income | 1.58B | 2.11B | 2.08B | 2.66B | 2.47B | 814.80M |
Balance Sheet | ||||||
| Total Assets | 14.39B | 12.99B | 10.94B | 9.49B | 6.04B | 3.67B |
| Cash, Cash Equivalents and Short-Term Investments | 601.91M | 964.35M | 954.74M | 742.76M | 2.66B | 1.34B |
| Total Debt | 902.63M | 955.88M | 1.31B | 978.44M | 277.96M | 210.41M |
| Total Liabilities | 6.15B | 4.72B | 3.52B | 3.18B | 1.47B | 912.93M |
| Stockholders Equity | 8.18B | 8.23B | 7.37B | 6.33B | 4.58B | 2.76B |
Cash Flow | ||||||
| Free Cash Flow | 1.14B | 1.90B | 1.22B | 787.50M | -1.27B | 1.11B |
| Operating Cash Flow | 1.30B | 2.35B | 1.71B | 3.09B | 3.03B | 1.20B |
| Investing Cash Flow | -424.99M | -818.88M | -903.88M | -4.28B | -873.80M | -540.80M |
| Financing Cash Flow | -589.90M | -1.63B | -620.77M | -649.88M | -641.01M | -275.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$17.20B | 11.60 | 10.90% | 9.92% | -2.79% | -39.45% | |
72 Outperform | HK$11.68B | -9.03 | 6.97% | ― | -20.50% | -64.45% | |
71 Outperform | HK$14.56B | 23.58 | 3.92% | 9.28% | -5.78% | -29.52% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
60 Neutral | HK$1.50B | -8.58 | 6.31% | 4.24% | -26.28% | -69.55% | |
56 Neutral | HK$2.11B | 4.52 | 3.21% | 20.68% | -23.72% | -86.69% | |
47 Neutral | HK$8.85B | -47.23 | 17.81% | 1.53% | -20.71% | 209.68% |